Melanoma Research Alliance
The MRA announces its eighth annual Request for Proposals (RFP), soliciting translational research grant applications from scientists and clinicians around the world. The RFP calls for ideas that could lead to high impact near-term clinical application in melanoma detection, prevention, diagnosis, staging, or treatment.
MRA will accept proposals for Established Investigator Awards, Pilot Awards, Young Investigator Awards, Academic-Industry Partnership Awards (Established Investigator and Teams), and Special Opportunity Awards. Several special opportunities are being made possible in collaboration with Amgen, Bristol-Myers Squibb (BMS), and the Society for Immunotherapy of Cancer (SITC).
In addition, we are pleased to announce a Young Investigator award in Dermatology. During this cycle, MRA plans to award at least $7 million to new projects.
Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma.
November 11, 2014: Young Investigator Award (including Dermatology Young Investigators), Established Investigator Award (including BMS-MRA Established Investigators), and Pilot Award (including SITC-MRA Pilot Award) proposals are due.
November 21, 2014: All Academic-Industry Partnership Award (for Established Investigators and Teams) and BMS-MRA Team Science Award proposals are due.
IISPV's deadline: October 10, 2014 (europa@iispv.cat)
Full proposal: IISPV's deadline: November 3, 2014
Work
C/ Dr. Mallafrè Guasch, 4
Edifici modular Hospital Universitari de Tarragona Joan XXIII
43007 Tarragona
Tel./Fax Work977 24 97 72 http://www.iispv.cathttp://www.iispv.cat
Work
C/ Sant Llorenç, 21
Planta baixa de l'edifici 4 de la Facultat de Medicina i Ciències de la Salut
43201 Reus (Tarragona)
Tel./Fax Work977 75 93 96 / 977 75 93 95
Fax977 75 93 93
http://www.iispv.cathttp://www.iispv.cat